John F. Rex's most recent trade in Unitedhealth Group Inc was a trade of 131 Common Stock done . Disclosure was reported to the exchange on June 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| UnitedHealth | John F. Rex | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 131 | 203,898 (0%) | 0% | 0 | Common Stock | |
| UnitedHealth | John F. Rex | President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 306.45 per share. | 03 Jun 2025 | 29 | 203,766 (0%) | 0% | 306.4 | 8,887 | Common Stock |
| UnitedHealth | John F. Rex | President & CFO | Purchase of securities on an exchange or from another person at price $ 291.12 per share. | 16 May 2025 | 17,175 | 203,796 (0%) | 0% | 291.1 | 4,999,919 | Common Stock |
| UnitedHealth | John F. Rex | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2025 | 75 | 186,621 (0%) | 0% | 0 | Common Stock | |
| UnitedHealth | John F. Rex | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 31,657 | 31,657 | - | - | Non-Qualified Stock Options (right to buy) | |
| UnitedHealth | John F. Rex | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 11,763 | 187,448 (0%) | 0% | 0 | Common Stock | |
| UnitedHealth | John F. Rex | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 7,464 | 189,125 (0%) | 0% | 0 | Common Stock | |
| UnitedHealth | John F. Rex | President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 502.45 per share. | 20 Feb 2025 | 5,787 | 181,661 (0%) | 0% | 502.5 | 2,907,704 | Common Stock |
| UnitedHealth | John F. Rex | President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 466.52 per share. | 20 Feb 2025 | 1,078 | 188,047 (0%) | 0% | 466.5 | 502,909 | Common Stock |
| UnitedHealth | John F. Rex | President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 466.51 per share. | 20 Feb 2025 | 823 | 187,223 (0%) | 0% | 466.5 | 383,941 | Common Stock |
| UnitedHealth | John F. Rex | President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 467.02 per share. | 20 Feb 2025 | 678 | 186,545 (0%) | 0% | 467.0 | 316,639 | Common Stock |
| UnitedHealth | John F. Rex | President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 523.60 per share. | 14 Feb 2025 | 799 | 175,685 (0%) | 0% | 523.6 | 418,354 | Common Stock |
| UnitedHealth | John F. Rex | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 25,504 | 0 | - | - | Non-Qualified Stock Options (right to buy) | |
| UnitedHealth | John F. Rex | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 108.97 per share. | 07 Feb 2025 | 25,504 | 191,690 (0%) | 0% | 109.0 | 2,779,171 | Common Stock |
| UnitedHealth | John F. Rex | President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 531.48 per share. | 07 Feb 2025 | 15,206 | 176,484 (0%) | 0% | 531.5 | 8,081,685 | Common Stock |
| UnitedHealth | John F. Rex | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2024 | 77 | 166,186 (0%) | 0% | 0 | Common Stock | |
| UnitedHealth | John F. Rex | President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 607.00 per share. | 13 Nov 2024 | 314 | 166,109 (0%) | 0% | 607 | 190,598 | Common Stock |
| UnitedHealth | John F. Rex | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2024 | 66 | 166,423 (0%) | 0% | 0 | Common Stock | |
| UnitedHealth | John F. Rex | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 76 | 166,357 (0%) | 0% | 0 | Common Stock | |
| UnitedHealth | John F. Rex | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 1,125 | 1,125 | - | - | Non-Qualified Stock Options (right to buy) | |
| UnitedHealth | John F. Rex | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 302 | 166,281 (0%) | 0% | 0 | Common Stock | |
| UnitedHealth | John F. Rex | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2024 | 67 | 165,979 (0%) | 0% | 0 | Common Stock | |
| UnitedHealth | John Rex F. | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 526.57 per share. | 22 Feb 2024 | 1,061 | 166,581 (0%) | 0% | 526.6 | 558,689 | Common Stock |
| UnitedHealth | F. Rex John | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 527.79 per share. | 22 Feb 2024 | 669 | 165,911 (0%) | 0% | 527.8 | 353,092 | Common Stock |
| UnitedHealth | F. Rex John | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 26,154 | 26,154 | - | - | Non-Qualified Stock Options (right to buy) | |
| UnitedHealth | John F. Rex | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 18,088 | 169,645 (0%) | 0% | 0 | Common Stock | |
| UnitedHealth | John F. Rex | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 521.99 per share. | 21 Feb 2024 | 8,899 | 160,745 (0%) | 0% | 522.0 | 4,645,166 | Common Stock |
| UnitedHealth | F. John Rex | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 6,897 | 167,642 (0%) | 0% | 0 | Common Stock | |
| UnitedHealth | John F. Rex | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 516.88 per share. | 13 Feb 2024 | 924 | 152,343 (0%) | 0% | 516.9 | 477,593 | Common Stock |
| UnitedHealth | Rex F. John | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.25 per share. | 13 Feb 2024 | 786 | 151,557 (0%) | 0% | 517.2 | 406,555 | Common Stock |
| UnitedHealth | F. John Rex | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 550.30 per share. | 12 Dec 2023 | 298 | 153,267 (0%) | 0% | 550.3 | 163,990 | Common Stock |
| UnitedHealth | John F. Rex | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2023 | 63 | 153,566 (0%) | 0% | 0 | Common Stock | |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2023 | 71 | 153,502 (0%) | 0% | 0 | Common Stock | |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 71 | 153,431 (0%) | 0% | 0 | Common Stock | |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2023 | 62 | 153,360 (0%) | 0% | 0 | Common Stock | |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 24,928 | 24,928 | - | - | Non-Qualified Stock Options (right to buy) | |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 491.69 per share. | 23 Feb 2023 | 17,423 | 155,847 (0%) | 0% | 491.7 | 8,566,715 | Common Stock |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 491.70 per share. | 23 Feb 2023 | 8,572 | 147,275 (0%) | 0% | 491.7 | 4,214,824 | Common Stock |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 491.69 per share. | 23 Feb 2023 | 6,814 | 154,089 (0%) | 0% | 491.7 | 3,350,376 | Common Stock |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 484.60 per share. | 23 Feb 2023 | 791 | 153,297 (0%) | 0% | 484.6 | 383,321 | Common Stock |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 489.08 per share. | 22 Feb 2023 | 1,942 | 144,419 (0%) | 0% | 489.1 | 949,788 | Common Stock |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 488.98 per share. | 22 Feb 2023 | 910 | 143,509 (0%) | 0% | 489.0 | 444,975 | Common Stock |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 495.55 per share. | 13 Feb 2023 | 1,774 | 142,581 (0%) | 0% | 495.6 | 879,107 | Common Stock |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 492.99 per share. | 13 Feb 2023 | 1,367 | 143,117 (0%) | 0% | 493.0 | 673,914 | Common Stock |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 495.62 per share. | 13 Feb 2023 | 831 | 141,749 (0%) | 0% | 495.6 | 411,862 | Common Stock |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 493.33 per share. | 13 Feb 2023 | 640 | 142,476 (0%) | 0% | 493.3 | 315,730 | Common Stock |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 538.50 per share. | 13 Dec 2022 | 819 | 140,806 (0%) | 0% | 538.5 | 441,029 | Common Stock |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2022 | 57 | 141,625 (0%) | 0% | 0 | Common Stock | |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Sep 2022 | 59 | 141,567 (0%) | 0% | 0 | Common Stock | |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jul 2022 | 44,757 | 0 | - | - | Non-qualified stock options (right to buy) | |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 70.24 per share. | 29 Jul 2022 | 44,757 | 179,673 (0%) | 0% | 70.2 | 3,143,732 | Common Stock |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 539.37 per share. | 29 Jul 2022 | 24,982 | 154,691 (0%) | 0% | 539.4 | 13,474,541 | Common Stock |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 541.53 per share. | 29 Jul 2022 | 13,183 | 141,508 (0%) | 0% | 541.5 | 7,138,990 | Common Stock |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2022 | 60 | 134,916 (0%) | 0% | 0 | Common Stock | |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2022 | 53 | 134,855 (0%) | 0% | 0 | Common Stock | |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 475.75 per share. | 25 Feb 2022 | 859 | 129,261 (0%) | 0% | 475.7 | 408,669 | Common Stock |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 462.51 per share. | 22 Feb 2022 | 1,085 | 130,120 (0%) | 0% | 462.5 | 501,823 | Common Stock |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2022 | 26,885 | 26,885 | - | - | Non-Qualified Stock Option (right to buy) | |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 474.40 per share. | 14 Feb 2022 | 17,835 | 133,445 (0%) | 0% | 474.4 | 8,460,924 | Common Stock |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 474.40 per share. | 14 Feb 2022 | 8,775 | 124,670 (0%) | 0% | 474.4 | 4,162,860 | Common Stock |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2022 | 6,535 | 131,205 (0%) | 0% | 0 | Common Stock | |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.13 per share. | 13 Feb 2022 | 945 | 115,610 (0%) | 0% | 478.1 | 451,833 | Common Stock |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.13 per share. | 13 Feb 2022 | 721 | 116,555 (0%) | 0% | 478.1 | 344,732 | Common Stock |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 58 | 117,276 (0%) | 0% | 0 | Common Stock | |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Sep 2021 | 68 | 117,217 (0%) | 0% | 0 | Common Stock | |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jul 2021 | 52,972 | 0 | - | - | Non-qualified stock options (right to buy) | |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.38 per share. | 29 Jul 2021 | 52,972 | 162,402 (0%) | 0% | 57.4 | 3,039,533 | Common Stock |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 411.53 per share. | 29 Jul 2021 | 29,815 | 132,587 (0%) | 0% | 411.5 | 12,269,767 | Common Stock |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 411.84 per share. | 29 Jul 2021 | 8,376 | 124,211 (0%) | 0% | 411.8 | 3,449,555 | Common Stock |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 412.27 per share. | 29 Jul 2021 | 7,062 | 117,149 (0%) | 0% | 412.3 | 2,911,472 | Common Stock |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 70 | 109,430 (0%) | 0% | 0 | Common Stock | |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Mar 2021 | 6,519 | 12,331 (0%) | 0% | 0 | Common Stock | |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2021 | 65 | 109,360 (0%) | 0% | 0 | Common Stock | |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 332.22 per share. | 26 Feb 2021 | 847 | 102,775 (0%) | 0% | 332.2 | 281,390 | Common Stock |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2021 | 40,703 | 40,703 | - | - | Non-Qualified Stock Option (right to buy) | |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 327.64 per share. | 22 Feb 2021 | 16,768 | 103,173 (0%) | 0% | 327.6 | 5,493,868 | Common Stock |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2021 | 8,699 | 103,622 (0%) | 0% | 0 | Common Stock | |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 327.64 per share. | 22 Feb 2021 | 8,250 | 94,923 (0%) | 0% | 327.6 | 2,703,030 | Common Stock |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 328.24 per share. | 12 Feb 2021 | 932 | 86,405 (0%) | 0% | 328.2 | 305,920 | Common Stock |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 328.24 per share. | 12 Feb 2021 | 712 | 87,337 (0%) | 0% | 328.2 | 233,707 | Common Stock |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 324.34 per share. | 08 Feb 2021 | 1,024 | 88,049 (0%) | 0% | 324.3 | 332,124 | Common Stock |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2020 | 64 | 89,073 (0%) | 0% | 0 | Common Stock | |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Sep 2020 | 74 | 89,008 (0%) | 0% | 0 | Common Stock | |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 56.04 per share. | 17 Jul 2020 | 80,000 | 157,847 (0%) | 0% | 56.0 | 4,483,200 | Common Stock |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2020 | 80,000 | 0 | - | - | Non-Qualified Stock Options | |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 308.66 per share. | 17 Jul 2020 | 46,739 | 111,108 (0%) | 0% | 308.7 | 14,426,460 | Common Stock |
| UnitedHealth | John F. Rex | EVP Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 308.43 per share. | 17 Jul 2020 | 22,174 | 88,934 (0%) | 0% | 308.4 | 6,839,105 | Common Stock |